Down arrowContact us

Geneva

Berne

Nyon

Zurich

Paris

London

Montevideo

Singapore

Turks and Caicos

Home
| Disclaimer | Legal information | Site map | Down arrowSearch ...

Portfolio management

...........................

Aberdeen AM

Air Liquide

Aixtron

Allianz

Aviva

BG GROUP

BHP Billiton

BMW

Danone

Delhaize Group

Deutsche Bank

EADS

France Telecom

Gemalto

Getinge

HSBC

Inditex

Integra

L'Oréal

Lindt & Sprungli

LVMH

Metro

Nordea

Novartis

Novatek

PGS

Qiagen

Reed Elsevier

Remy Cointreau

Roche

Rosneft

SAP

SGS

Snam Rete Gas

Société Générale

Sodexo

Syngenta

Telefonica

Temenos

Total

UBS

Vallourec

Vodafone

WPP

X5 Retail Group

Xstrata

Zurich Financial Services

Links FR | DE | ES Print

European equity research

Industry search

> Deutsche Bank

> X5 Retail Group

> Qiagen

> Roche

> Novartis

We follow a sectoral approach throughout Europe and our reference index is the DJ Stoxx 600. Our list of recommended securities comprises between 30 and 40 companies. Our recommendation codes are drawn up in a spirit of relative performance against the sectoral indexes, but the general aim of our recommendations is to outperform the DJ Stoxx 600:


«MINUS»
underperformance

«PLUS»
outperformance
«PLUS R»
outperformance
with risk

As long as we recommend a stock ("Plus" code), we issue follow-up information sheets and commentaries on every important event. When we adopt a "Minus" code, we continue to monitor the stock for three months before suspending our work. Our analyses are based on traditional quantitative (valuation ratios, balance sheets, profit and loss accounts, prospects etc) and qualitative methods (products, contacts with management, seminars, visits to competitors etc). We systematically compare our conclusions with the consensus view before issuing a rating.

To verify and make a critical assessment of our recommendations, each one of them is placed before the team of analysts.